All these findings suggest that the aberrant expressions of TRIM28/SETDB1 in CeD patients might influence the epigenetic differentiation, expansion, and function of immunity towards a peculiar reactivity in genetically pre-disposed individuals. This evidence concerns the gene TRIM28 and cranioectodermal dysplasia.